Trademark: 90274108
Status Date
Tuesday, December 26, 2023
Filing Date
Friday, October 23, 2020
Published for Opposition
Tuesday, October 31, 2023
36 Pharmacy benefit management services; medical benefit management services; medical and pharmacy benefit management services, namely, tracking, monitoring, assessing and analyzing information and statistics regarding patient prescription drug use, medical care, and healthcare habits, to identify potential cost savings and clinical benefits; claims administration services in the field of health insurance; medical insurance case and utilization review and insurance claims adjustment services for healthcare purchasers, payers, providers, and beneficiaries of health plans; administration of managed health care plans; organization and coordination of health benefits, namely utilization management, prior authorization, and claims adjudication
35 Cost management for the health and prescription drug plans of others in the field of pharmaceuticals, clinical care and health care treatment; business services in the nature of pharmaceutical cost management, namely, prescription drug formulary cost management services; consulting services in the cost management of healthcare and pharmacy services; Pharmaceutical cost management services and drug utilization review services; medical cost management; managed care services, namely, utilization review and pre-certification services; evidence-based health care cost management services and healthcare utilization and review services; patient relationship management services and pharmaceutical cost management; medical and pharmaceutical cost management services in the fields of medical oncology, radiation therapy, genetic laboratory services, diagnostic radiology, inpatient admissions, cancer surgery, and healthcare services in the field of oncology; Drug utilization review services and drug formulary cost and business management services; strategic business analysis and business advice regarding pharmacy benefit management, pharmaceutical end-user behavior, healthcare use behavior; market study and analysis of market studies in the fields of healthcare, healthcare benefits, and pharmacy benefits effecting health behavior change and choice at the patient level, providing business intelligence services in the field of pharmacy benefit management; Cost management and business management of the health care benefit plans of others in the field of oncology, namely, management related to chemotherapy benefits, infusion treatment benefits, injection treatment benefits and other treatment benefits in the field of oncology
44 Advisory services and consultancy in the field of healthcare; healthcare services, namely, disease management programs; clinical decision support for medical oncology services, radiation therapy, diagnostic radiology services, hospital admissions, and surgery
Dec 26, 2023
Noa E-Mailed - Sou Required From Applicant
Oct 31, 2023
Official Gazette Publication Confirmation E-Mailed
Oct 31, 2023
Published For Opposition
Oct 11, 2023
Notification Of Notice Of Publication E-Mailed
Sep 25, 2023
Approved For Pub - Principal Register
Sep 20, 2023
Examiner's Amendment Entered
Sep 20, 2023
Notification Of Examiners Amendment E-Mailed
Sep 20, 2023
Examiners Amendment E-Mailed
Sep 20, 2023
Examiners Amendment -Written
Aug 22, 2023
Suspension Checked ¿ To Attorney For Action
May 16, 2023
Assigned To Examiner
Apr 19, 2023
Automatic Update Of Assignment Of Ownership
Feb 2, 2023
Report Completed Suspension Check Case Still Suspended
Jun 6, 2022
Report Completed Suspension Check Case Still Suspended
Nov 4, 2021
Notification Of Letter Of Suspension E-Mailed
Nov 4, 2021
Letter Of Suspension E-Mailed
Nov 4, 2021
Suspension Letter Written
Sep 21, 2021
Teas/Email Correspondence Entered
Sep 21, 2021
Correspondence Received In Law Office
Sep 21, 2021
Teas Response To Office Action Received
Mar 29, 2021
Notification Of Non-Final Action E-Mailed
Mar 29, 2021
Non-Final Action E-Mailed
Mar 29, 2021
Non-Final Action Written
Mar 29, 2021
Notification Of Non-Final Action E-Mailed
Mar 29, 2021
Non-Final Action E-Mailed
Mar 29, 2021
Non-Final Action Written
Mar 24, 2021
Assigned To Examiner
Dec 12, 2020
New Application Office Supplied Data Entered
Oct 27, 2020
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
